Pergolizzi Joseph V, Magnusson Peter, Christo Paul J, LeQuang Jo Ann, Breve Frank, Mitchell Kailyn, Varrassi Giustino
NEMA Research, Inc., Naples, FL, United States.
Centre for Research & Development, Uppsala University, Uppsala, Sweden.
Front Pain Res (Lausanne). 2021 Nov 16;2:691720. doi: 10.3389/fpain.2021.691720. eCollection 2021.
A clinical conundrum can occur when a patient with active opioid use disorder (OUD) or at elevated risk for the condition presents with cancer and related painful symptoms. Despite earlier beliefs that cancer patients were relatively unaffected by opioid misuse, it appears that cancer patients have similar risks as the general population for OUD but are more likely to need and take opioids. Treating such patients requires an individualized approach, informed consent, and a shared decision-making model. Tools exist to help stratify patients for risk of OUD. While improved clinician education in pain control is needed, patients too need to be better informed about the risks and benefits of opioids. Patients may fear pain more than OUD, but opioids are not always the most effective pain reliever for a given patient and some patients do not tolerate or want to take opioids. The association of OUD with mental health disorders (dual diagnosis) can also complicate delivery of care as patients with mental health issues may be less adherent to treatment and may use opioids for "chemical coping" as much as for pain control.
当患有活动性阿片类物质使用障碍(OUD)或该疾病风险升高的患者出现癌症及相关疼痛症状时,可能会出现临床难题。尽管早期认为癌症患者相对不受阿片类物质滥用的影响,但似乎癌症患者患OUD的风险与普通人群相似,但更有可能需要并服用阿片类药物。治疗此类患者需要个性化方法、知情同意和共同决策模型。现有工具可帮助对患者的OUD风险进行分层。虽然需要改善临床医生在疼痛控制方面的教育,但患者也需要更好地了解阿片类药物的风险和益处。患者可能更害怕疼痛而不是OUD,但阿片类药物并不总是对特定患者最有效的止痛剂,有些患者无法耐受或不想服用阿片类药物。OUD与精神健康障碍(双重诊断)的关联也会使护理变得复杂,因为有精神健康问题的患者可能不太坚持治疗,可能将阿片类药物用于“化学应对”以及疼痛控制。